CU23776B7 - COMPOSITIONS WITH IRON SUPPLEMENT WITH IMPROVED TOLERANCE - Google Patents

COMPOSITIONS WITH IRON SUPPLEMENT WITH IMPROVED TOLERANCE

Info

Publication number
CU23776B7
CU23776B7 CU20080054A CU20080054A CU23776B7 CU 23776 B7 CU23776 B7 CU 23776B7 CU 20080054 A CU20080054 A CU 20080054A CU 20080054 A CU20080054 A CU 20080054A CU 23776 B7 CU23776 B7 CU 23776B7
Authority
CU
Cuba
Prior art keywords
compositions
iron
improved tolerance
iron supplement
effective amount
Prior art date
Application number
CU20080054A
Other languages
Spanish (es)
Other versions
CU20080054A7 (en
Inventor
Peter Krebs
Jerome Mincy
Allison Krebs-Bensch
Original Assignee
Grace Procurements Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37902204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23776(B7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grace Procurements Llc filed Critical Grace Procurements Llc
Publication of CU20080054A7 publication Critical patent/CU20080054A7/en
Publication of CU23776B7 publication Critical patent/CU23776B7/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a composiciones y métodos para el tratamiento y profilaxis de la deficiencia de hierro, y en particular de anemia por deficiencia de hierro, por la administración de una composición que contiene una cantidad eficaz de una sal farmacéuticamente aceptable de hierro ferroso; y una cantidad eficaz de complejo de hierro polisacárido.The invention relates to compositions and methods for the treatment and prophylaxis of iron deficiency, and in particular of iron deficiency anemia, by the administration of a composition containing an effective amount of a pharmaceutically acceptable salt of ferrous iron; and an effective amount of polysaccharide iron complex.

CU20080054A 2005-10-04 2008-04-04 COMPOSITIONS WITH IRON SUPPLEMENT WITH IMPROVED TOLERANCE CU23776B7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/243,043 US20070077313A1 (en) 2005-10-04 2005-10-04 Toleration iron supplement compositions

Publications (2)

Publication Number Publication Date
CU20080054A7 CU20080054A7 (en) 2010-08-30
CU23776B7 true CU23776B7 (en) 2012-02-15

Family

ID=37902204

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20080054A CU23776B7 (en) 2005-10-04 2008-04-04 COMPOSITIONS WITH IRON SUPPLEMENT WITH IMPROVED TOLERANCE

Country Status (10)

Country Link
US (2) US20070077313A1 (en)
EP (1) EP1945032A4 (en)
CA (1) CA2624619C (en)
CR (1) CR9857A (en)
CU (1) CU23776B7 (en)
EC (1) ECSP088348A (en)
HN (1) HN2008000582A (en)
SV (1) SV2009002862A (en)
TW (1) TWI358299B (en)
WO (1) WO2007044180A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
EP2526950A1 (en) * 2006-04-07 2012-11-28 Merrion Research III Limited Solid oral dosage form containing an enhancer
KR20110007614A (en) * 2008-05-07 2011-01-24 메리온 리서치 Ⅲ 리미티드 Compositions of gnrh related compounds and processes of preparation
TWI480286B (en) * 2009-02-25 2015-04-11 Merrion Res Iii Ltd Composition and drug delivery of bisphosphonates
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
CN103476419A (en) * 2011-01-07 2013-12-25 梅里翁第三研究有限公司 Pharmaceutical compositions of iron for oral administration
CN102167752B (en) * 2011-05-23 2012-08-08 华南理工大学 Preparation method of water-soluble soybean polysaccharide ferrous coordination compound
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
IT1251702B (en) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl IRON COMPLEXES WITH CONALBUMIN AND ITS DERIVATIVES
DK1169062T3 (en) * 1999-04-09 2010-01-25 Amag Pharmaceuticals Inc Heat stable coated colloidal iron oxides
US20030190355A1 (en) * 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
DE60335426D1 (en) * 2002-08-15 2011-01-27 Euro Celtique Sa Pharmaceutical compositions containing an opioid antagonist
CN1933873A (en) * 2004-03-19 2007-03-21 沃纳奇尔科特公司 Extended cycle multiphasic oral contraceptive method
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia

Also Published As

Publication number Publication date
US20070077313A1 (en) 2007-04-05
CU20080054A7 (en) 2010-08-30
ECSP088348A (en) 2008-07-30
US20110052722A1 (en) 2011-03-03
CA2624619A1 (en) 2007-04-19
CR9857A (en) 2008-07-29
EP1945032A2 (en) 2008-07-23
EP1945032A4 (en) 2009-04-15
TWI358299B (en) 2012-02-21
WO2007044180A2 (en) 2007-04-19
HN2008000582A (en) 2011-11-09
SV2009002862A (en) 2009-01-27
CA2624619C (en) 2018-03-13
WO2007044180A3 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
CU20080054A7 (en) COMPOSITIONS WITH IRON SUPPLEMENT WITH IMPROVED TOLERANCE
MX2007008790A (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use.
IN2012DN04940A (en)
PE20061122A1 (en) COMPOSITIONS INCLUDING IRON
UY31789A1 (en) SUPER FAST PERFORMANCE INSULIN COMPOSITIONS
ATE447568T1 (en) NEW PYRINE DERIVATIVES
AR054525A1 (en) COMPOSITIONS AND METHODS FOR THE PROCESSING OF SYMPTOMS RELATED TO THE CYCLE
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
MX2012012837A (en) Pharmaceutical compositions and methods of making same.
AR050717A1 (en) PHARMACEUTICAL COMPOSITIONS
PE20142314A1 (en) INTRANASAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
CR11418A (en) TRANS-CLOMPHENE FOR METABOLIC SYNDROME
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
TW200700071A (en) Novel use
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
UY29236A1 (en) 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDAS. ITS PREPARATION, COMPOSITIONS THAT CONTAIN THEM AND ITS USE.
CL2009002129A1 (en) Carboxyamide derivatives of lantibiotics; preparation process of said lantibiotics; pharmaceutical composition containing it; Useful in the treatment of bacterial infections.
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
AR111471A2 (en) SYNERGIC COMBINATION COMPOSITION
MX2007006042A (en) Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof.
TW200726460A (en) Anti-fatigue composition
BRPI0509667A (en) Substituted azaquinazolines with antiviral efficacy
AR062248A1 (en) COMPOSITIONS AND METHODS TO TREAT REUMATOID ARTHRITIS
AR048167A1 (en) DIETARY SUPPLEMENT WITH ESTEQUIOMETRICALLY SPECIFICATIONS OF POTASSIUM AND MAGNESIUM CITRATE

Legal Events

Date Code Title Description
FG Grant of patent